KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Evolent Health (EVH) EBIAT (2016 - 2025)

Evolent Health has reported EBIAT over the past 12 years, most recently at -$429.1 million for Q4 2025.

  • Quarterly results put EBIAT at -$429.1 million for Q4 2025, down 1781.99% from a year ago — trailing twelve months through Dec 2025 was -$534.5 million (down 767.39% YoY), and the annual figure for FY2025 was -$534.5 million, down 767.39%.
  • EBIAT for Q4 2025 was -$429.1 million at Evolent Health, down from -$20.9 million in the prior quarter.
  • Over the last five years, EBIAT for EVH hit a ceiling of $3.1 million in Q4 2021 and a floor of -$429.1 million in Q4 2025.
  • Median EBIAT over the past 5 years was -$18.6 million (2024), compared with a mean of -$37.9 million.
  • Biggest five-year swings in EBIAT: skyrocketed 128.7% in 2021 and later tumbled 1781.99% in 2025.
  • Evolent Health's EBIAT stood at $3.1 million in 2021, then plummeted by 486.9% to -$11.8 million in 2022, then plummeted by 182.86% to -$33.4 million in 2023, then soared by 31.75% to -$22.8 million in 2024, then tumbled by 1781.99% to -$429.1 million in 2025.
  • The last three reported values for EBIAT were -$429.1 million (Q4 2025), -$20.9 million (Q3 2025), and -$19.9 million (Q2 2025) per Business Quant data.